The current level reflects an upward revision of 54.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period. Ahead of a company's earnings disc...
Because if I understood you, some of these are temporary factors. If I look at your inventory on hand, I don’t think your customers stock up to 12 months. So shouldn’t some of these factors were — how conservative is this guidance for the back half? And on Chemistry X, I think ...
Moving through the P&L, I will highlight non-GAAP results that include stock-based compensation. I encourage you to review the GAAP reconciliation of these non-GAAP measures, which can be found in today’s release and the supplementary data available on our website. Please note that all sub...